Actively Recruiting
Vascular Changes Associated With Endophthalmitis
Led by Asociación para Evitar la Ceguera en México · Updated on 2025-09-16
71
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating vascular changes linked to exogenous endophthalmitis, a serious eye infection, by using detailed imaging techniques. This observational study aims to better understand how blood vessels change during the infection and recovery phases. It also plans to create a photo library to document these vascular changes, helping to distinguish effects caused by immune response, drug toxicity, or reduced blood flow. The study is conducted at the Asociaci f3n para Evitar la Ceguera en M e9xico and involves patients with a history of endophthalmitis who meet specific resolution criteria. The study uses multimodal imaging including fundus photography, optical coherence tomography, and fluorescein angiography to examine the eyes. These tests are performed twice: once seven days and again one month after patients meet the infection inactivation criteria set by the Mexican Endophthalmitis Study Group. This approach allows researchers to monitor and characterize vascular changes over time without administering any treatment, as this is an observational study. Participants will undergo clinical evaluations including visual acuity tests at each visit scheduled at seven days and one month post-inactivation. Imaging procedures will be repeated at these visits to capture detailed vascular changes. Researchers will collect comprehensive clinical data including medical histories, eye examinations, and laboratory results. The study emphasizes careful monitoring and documentation to improve understanding of endophthalmitis outcomes. Participation duration varies based on individual recovery timelines, with no investigational treatments applied.
CONDITIONS
Brief Title
Vascular Changes Associated With Endophthalmitis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a history of endophthalmitis diagnosis
- Clinical symptoms including pain, decreased visual acuity, anterior chamber cells and/or vitreous turbidity, corneal edema, conjunctival hyperemia
- Laboratory confirmation using B-mode ultrasound or positive culture
- Patients meeting the endophthalmitis resolution criteria of the Mexican Endophthalmitis Study Group
- Patients with previously signed informed consent
You will not qualify if you...
- Patients who have not signed informed consent
- Patients under 18 years old
- Patients with endophthalmitis who do not meet the resolution criteria of the Mexican Endophthalmitis Study Group
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo multimodal imaging tests including Fundus photography, Optical Coherence Tomography, and Fluorescein Angiography to assess vascular changes 7 days after meeting the inactivation criteria for endophthalmitis.
1 visit (in-person)
Duration - Approximately 3 weeks after initial imaging
Participants are monitored with repeated imaging and assessments one month after meeting the inactivation criteria to observe changes over time.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Hospital Asociación Para Evitar la Ceguera en México I.A.P.
Mexico City, Mexico, 04030
Actively Recruiting
Research Team
R
Raúl Velez Montoya, MD
B
Benjamín Aboytes Ríos, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here